Pet - Quo vadis?;Pet - Quo vadis?

Pneumologie

Volumn 55, Issue 8, 2001, Pages 361-362

  Huber, R M ^a   Thomas, M ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EDITORIAL; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; MEDIASTINUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034889744     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16205     Document Type: Editorial

References (9)

1. Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a sub-classification and implications
2. Differentialindikation zur induktionstherapie bei nicht-kleinzelligen lungentumoren
3. Aussagekraft der positronen-emissions-tomographie mit f-18-fluordesoxyglukose (FDG-PET) beim bronchioloalveolarzell-karzinom (BAC)
4. Metaanalyse zum stellenwert der positronen-emissions-tomographie mit f-18-fluordesoxyglukose (FDG-PET) bei lungentumoren
5. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
6. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
7. Preresectional chemotherapy in stage III A non-small-cell lung cancer: A 7 year assessment of a randomized controlled trial
8. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III A non-small-cell lung cancer
9. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III A non-small cell lung cancer